Asthma
Conference Coverage
Mepolizumab reduced exacerbations in patients with asthma and atopy, depression comorbidities
Few studies have examined the efficacy of mepolizumab therapy for patients with asthma and comorbidities.
Conference Coverage
Peanut sublingual immunotherapy feasible and effective in toddlers
There was a “strong potential” for sustained unresponsiveness at 3 months for the toddlers who received the active treatment.
Conference Coverage
Asthma not an independent risk factor for severe COVID-19, hospitalization
There have been conflicting data on whether comorbid asthma is or is not a risk factor for more severe COVID-19.
News
Asthma-COPD overlap: Patients have high disease burden
Population-level burden of eosinophilic disease was greater in combination asthma-COPD than in either condition alone
News
Annual WCC visits significantly limit asthma worsening
Primary care pediatricians have a crucial role to play in chronic asthma management.
News
Does daily inhaler monitoring improve asthma outcomes in children?
Sensors that track preventive treatment adherence may improve symptom control but increase hospital visits.
News
E-cigarette use tied to increased COPD, asthma risk
The clinical outcome were consistent with studies assessing in vivo biomarkers of e-cigarette exposure in animal subjects, human participants, and...
News
Asthma guidelines update FeNO, intermittent ICS use
Updated asthma management guidelines expand the role for inhaled corticosteroids and fractional exhaled nitric oxide testing.
Conference Coverage
No evidence to guide selection of biologic for severe asthma
When the starting biologic doesn’t get the desired results, there is no evidence to show whether another will work better.
Commentary
Kids with food allergies the newest victims of COVID-19?